ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Telix Pharmaceuticals (US) INC

Official 2024 U.S. DOL Form 5500 summary for Telix Pharmaceuticals (US) INC (Telix Pharmaceuticals Retirement Plan · EIN 82-4003948 · PN 001): $17.78M net assets, 310 active participants, and $77.29 per $10,000 (77.29 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorTelix Pharmaceuticals (US) INC
Filing IdentifierTelix Pharmaceuticals Retirement Plan · EIN 82-4003948 · PN 001
Plan Category & State401(k) Defined Contribution (IN)
Asset-Size Peer Cohort$5M-$25M
Plan Net Assets (2024)$17.78M
Active Participants310
Direct Admin Fee Rate$77.29 per $10,000 (77.29 bps)
Cohort Peer Median$37.06 per $10,000 (37.06 bps)
Primary Recordkeeper / ProviderFidelity Investments
Schedule H Line 4a RemittanceSchedule H Line 4a Late Remittance Reported ($132,711, often administrative timing)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI